Search | IOVS | ARVO Journals

Showing 1 – 20 of 49

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Association between anatomical and clinical outcomes in patients treated with anti-vascular endothelial growth factor for neovascular age-related macular degeneration

Mark C Gillies; Vuong Nguyen; Calvo Pilar; Martin Puzo; Pierre-Henry GABRIELLE; Catherine P Creuzot Garcher; Florian Baudin; Benjamin Wolff; Louise O’ Toole; Laurent Castelnovo; Michel Guillaume; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4214. doi:

ARVO Annual Meeting Abstract June 2020

Ranibizumab or Aflibercept for Diabetic Macular Edema: One-Year Comparison of Real-World Outcomes from Fight Retinal Blindness! Registry.

SANJEEB BHANDARI; Vuong Nguyen; Samantha Fraser-Bell; Hemal Mehta; Francesco Viola; Florian Baudin; Pierre-Henry Gabrielle; Catherine P Creuzot Garcher; Mark C Gillies; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3289. doi:

ARVO Annual Meeting Abstract July 2019

Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration

Mark C Gillies; SANJEEB BHANDARI; Benjamin Wolff; Jennifer Joan Arnold; Rohan W Essex; Stephanie Young; David M Squirrell; Daniel Barthelmes; Vuong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):111. doi:

ARVO Annual Meeting Abstract July 2019

Outcomes of suspending VEGF inhibitors for neovascular age-related macular degeneration when lesions have been inactive for 3 months

Vuong Nguyen; Anagha Vaze; Samanta Fraser-Bell; Jennifer Joan Arnold; Rohan W Essex; Daniel Barthelmes; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):139. doi:

ARVO Annual Meeting Abstract July 2019

Observation of ranibizumab treatment in real-life conditions – an interim analysis of the myopic choroidal neovascularization (mCNV) population within the observational, non-interventional PACIFIC study

Kristina Markova; Christos Haritoglou; Matthias Iwersen; Ulrike Michel; Martina Junge; Peter Geuking; Katrin Lorenz; Thomas Ach; Ramin Khoramnia; Andreas Schmidt; Judith Becker; Erik Beeke; Mathias Müller-Holz; Daniel Barthelmes; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4320. doi:

ARVO Annual Meeting Abstract July 2019

Changes in real world treatment patterns for diabetic macular edema and five year treatment outcomes: data from the Fight Retinal Blindness! Project

SANJEEB BHANDARI; Anne Catherine Biechl; Jennifer Joan Arnold; Stephanie Young; Samanta Fraser-Bell; Hemal Mehta; Mark C Gillies; Daniel Barthelmes; Vuong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2602. doi:

ARVO Annual Meeting Abstract July 2019

Real-world outcomes in patients with macular oedema secondary to central retinal vein occlusion receiving intravitreal anti-VEGF therapy in a UK public hospital setting

Sarah Ah-Moye; Pardis Zalmay; Magnus Theodorsson; Martin Lynn Harris; Riaz Asaria; Adrian Hunt; Daniel Barthelmes; Mark C Gillies; Vuong Nguyen; Hemal Mehta

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4061. doi:

ARVO Annual Meeting Abstract July 2018

Trainee-led vs. specialist-led management of neovascular age-related macular degeneration.

Rohan W. Essex; Vuong Nguyen; Vincent Daien; Sarah Steinmann; Richard Walton; Mark C Gillies; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1463. doi:

ARVO Annual Meeting Abstract July 2018

Optical Coherence Tomography Angiography findings in patients with Fabry's disease

Joel Baur; Mayss Al-Sheikh; Daniel Barthelmes; Albina Nowak; Christian Böni; Sandrine Anne Zweifel

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4249. doi:

ARVO Annual Meeting Abstract July 2018

The outcomes of corneal cross-linking for Keratoconus from routine clinical practice across 3 sites in Australia: Results from the Save Sight Keratoconus Registry

Alex Ferdi; Vuong Nguyen; Jeremy Tan; Yves Kerdraon; John Males; Nigel Morlet; Peter Beckinsale; Richard A Mills; Chris Go; Mark Daniell; Elsie Chan; Daniel Barthelmes; Amparo Herrera-Bond; Marco Garcia; Mark C Gillies; Stephanie L Watson

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4380. doi:

ARVO Annual Meeting Abstract July 2018

Real-world visual outcomes at 24 weeks in patients with diabetic macular edema receiving aflibercept intravitreal injections as per UK license.

Charles Hennings; Mira Deshmukh; Vuong Nguyen; Martin Harris; Riaz Asaria; Daniel Barthelmes; Mark C Gillies; Hemal Mehta

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3616. doi:

ARVO Annual Meeting Abstract July 2018

A Probabilistic Forecast of 12 Month Visual Outcomes of nAMD

Vuong Nguyen; Kelvin Teo; Judy Simpson; Vincent Daien; Daniel Barthelmes; Mark C Gillies; Richard Walton

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):829. doi:

Articles July 2018

Safety and Feasibility of a Novel Sparse Optical Coherence Tomography Device for Patient-Delivered Retina Home Monitoring

PDF

Peter Maloca; Pascal W. Hasler; Daniel Barthelmes; Patrik Arnold; Mooser Matthias; Hendrik P. N. Scholl; Heinrich Gerding; Justus Garweg; Tjebo Heeren; Konstantinos Balaskas; J. Emanuel Ramos de Carvalho; Catherine Egan; Adnan Tufail; Sandrine A. Zweifel
TAGS: optical coherence tomography, retina, safety, eye
Trans. Vis. Sci. Tech.. 2018; 7(4):8. doi: https://doi.org/10.1167/tvst.7.4.8

Special Issue June 2018

The Proteomic Landscape in the Vitreous of Patients With Age-Related and Diabetic Retinal Disease

PDF

Christian Schori; Christian Trachsel; Jonas Grossmann; Ioanna Zygoula; Daniel Barthelmes; Christian Grimm
TAGS: diabetes mellitus, enzyme-linked immunosorbent assay, exudative age-related macular degeneration, proteins, proteome, retinal diseases, vitreous body, proteomics
Invest. Ophthalmol. Vis. Sci.. 2018; 59(4):AMD31-AMD40. doi: https://doi.org/10.1167/iovs.18-24122

Includes: Supplemental Content

Genetics August 2017

C2orf71 Mutations as a Frequent Cause of Autosomal-Recessive Retinitis Pigmentosa: Clinical Analysis and Presentation of 8 Novel Mutations

PDF

Christina Gerth-Kahlert; Amit Tiwari; James V. M. Hanson; Vaishnavi Batmanabane; Elias Traboulsi; Mark E. Pennesi; Abdullah A. Al-Qahtani; Byron L. Lam; John Heckenlively; Sandrine A. Zweifel; Ajoy Vincent; Fabienne Fierz; Daniel Barthelmes; Kari Branham; Naheed Khan; Angela Bahr; Luzy Baehr; István Magyar; Samuel Koller; Silvia Azzarello-Burri; Dunja Niedrist; Elise Heon; Wolfgang Berger
TAGS: autosomal recessive inheritance, de novo mutation, genes, mutation, phenotype, retinitis pigmentosa, language morphology, morphology, macular disorders
Invest. Ophthalmol. Vis. Sci.. 2017; 58(10):3840-3850. doi: https://doi.org/10.1167/iovs.17-21597

ARVO Annual Meeting Abstract June 2017

Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept (Eylea) intravitreal injections at fixed intervals as per UK license

Mehmet Ozturk; Martin Harris; Vuong Nguyen; Daniel Barthelmes; Mark C Gillies; Hemal Mehta

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):881. doi:

ARVO Annual Meeting Abstract June 2017

Reformation of ellipsoid zone in en face OCT imaging in patients with solar maculopathy and laser injuries

Jeanne Martine Gunzinger; Katrin Fasler; Peter Maloca; Pascal W. Hasler; Christian Böni; Daniel Barthelmes; Sandrine Anne Zweifel

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1302. doi:

ARVO Annual Meeting Abstract June 2017

RANIBIZUMAB VERSUS AFLIBERCEPT FOR THE TREATMENT OF PIGMENT EPITHELIAL DETACHMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: DATA FROM A PROSPECTIVE OBSERVATIONAL STUDY

Daniel Barthelmes; Anagha Vaze; Vuong Nguyen; Vincent Daien; Jennifer J Arnold; Stephanie H Young; Nigel Morlet; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):888. doi:

ARVO Annual Meeting Abstract June 2017

Twelve-month outcomes of ranibizumab versus aflibercept for neovascular age-related macular degeneration: an observational study.

Mark C Gillies; Vincent Daien; Vuong Nguyen; Jennifer J Arnold; Nigel Morlet; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):896. doi:

ARVO Annual Meeting Abstract June 2017

Social and clinical characteristics associated with low visual acuity at presentation of AMD

Vuong Nguyen; Vincent Daien; Robyn Guymer; Ian McAllister; Nigel Morlet; Daniel Barthelmes; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1524. doi:

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Association between anatomical and clinical outcomes in patients treated with anti-vascular endothelial growth factor for neovascular age-related macular degeneration

Ranibizumab or Aflibercept for Diabetic Macular Edema: One-Year Comparison of Real-World Outcomes from Fight Retinal Blindness! Registry.

Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration

Outcomes of suspending VEGF inhibitors for neovascular age-related macular degeneration when lesions have been inactive for 3 months

Observation of ranibizumab treatment in real-life conditions – an interim analysis of the myopic choroidal neovascularization (mCNV) population within the observational, non-interventional PACIFIC study

Changes in real world treatment patterns for diabetic macular edema and five year treatment outcomes: data from the Fight Retinal Blindness! Project

Real-world outcomes in patients with macular oedema secondary to central retinal vein occlusion receiving intravitreal anti-VEGF therapy in a UK public hospital setting

Trainee-led vs. specialist-led management of neovascular age-related macular degeneration.

Optical Coherence Tomography Angiography findings in patients with Fabry's disease

The outcomes of corneal cross-linking for Keratoconus from routine clinical practice across 3 sites in Australia: Results from the Save Sight Keratoconus Registry

Real-world visual outcomes at 24 weeks in patients with diabetic macular edema receiving aflibercept intravitreal injections as per UK license.

A Probabilistic Forecast of 12 Month Visual Outcomes of nAMD

Safety and Feasibility of a Novel Sparse Optical Coherence Tomography Device for Patient-Delivered Retina Home Monitoring

The Proteomic Landscape in the Vitreous of Patients With Age-Related and Diabetic Retinal Disease

C2orf71 Mutations as a Frequent Cause of Autosomal-Recessive Retinitis Pigmentosa: Clinical Analysis and Presentation of 8 Novel Mutations

Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept (Eylea) intravitreal injections at fixed intervals as per UK license

Reformation of ellipsoid zone in en face OCT imaging in patients with solar maculopathy and laser injuries

RANIBIZUMAB VERSUS AFLIBERCEPT FOR THE TREATMENT OF PIGMENT EPITHELIAL DETACHMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: DATA FROM A PROSPECTIVE OBSERVATIONAL STUDY

Twelve-month outcomes of ranibizumab versus aflibercept for neovascular age-related macular degeneration: an observational study.

Social and clinical characteristics associated with low visual acuity at presentation of AMD

To View More...

You must be signed into an individual account to use this feature.